The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool



Olsson-Brown, Anna, Piskilidis, Pavlos, O'Hagan, Julie, Thorp, Nicky, Robson, Peter, Innes, Helen, Wong, Helen, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Jackson, Richard, Kiernan, Tamara
et al (show 3 more authors) (2019) The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. BREAST, 44. 94 - 100.

[img] Text
CP FINAL Sept 2018 Olsson-Brown et al 2018.pdf - Accepted Version

Download (732kB)
[img] Text
CP FINAL complete Figures for oncotype paper.pdf - Accepted Version

Download (752kB)
Item Type: Article
Uncontrolled Keywords: Breast cancer, 21 gene recurrence score, MDT, Decision making
Depositing User: Symplectic Admin
Date Deposited: 09 Apr 2019 08:56
Last Modified: 13 Jan 2021 18:11
DOI: 10.1016/j.breast.2019.01.005
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3036239